Postpartum Health Supplements Market Size, Share & Trends Analysis Report By Product Type (Single Nutritional Supplements, Combined Nutritional Supplements), By Formulation, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Postpartum Health Supplements Market Size, Share & Trends Analysis Report By Product Type (Single Nutritional Supplements, Combined Nutritional Supplements), By Formulation, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Postpartum Health Supplements Market Growth & Trends

The global postpartum health supplements market size is anticipated to reach USD 2.13 billion by 2030 and is projected to grow at a CAGR of 8.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing prevalence of postnatal depression, which is one of the major factors driving its growth. According to the Office on Women's Health (OWH), One in 8 mothers register symptoms of postpartum depression in the year after childbirth. Also, it may harm the cognitive and social well-being of infants, children, and spouses. This has raised awareness as well as demand for these products.

The rising prevalence of sedentary lifestyle and growing consumption of unhealthy diets have increased the risk of diabetes, cardiovascular diseases, obesity, cancer, and other lifestyle diseases. Such risks may be amplified among women in the postpartum period as the body is recovering from childbirth and is vulnerable to diseases. The spread of the COVID-19 pandemic also raised concerns and awareness about the importance of a healthy lifestyle. It led to the adoption of fitness exercises & a healthy diet. Hence, several people are focusing on self-care and are tracking their nutrition & health. This changing lifestyle trend has improved the adoption of postpartum health supplements.

Furthermore, the market is experiencing increased product launches, including collagen, fiber, and choline supplements. Various participants are launching these supplements. For instance, in October 2023, LaVie Mom introduced Prebiotic Fiber Postpartum Gummy. Moreover, in March 2022, PurerVita, a supplement provider, introduced the PurerMama supplement line. The Purermama range includes The Postnatal Collagen, Purer Glow Superfood Collagen, The Choline Capsule, Purer Rage Superfood Collagen, and Purer Restore Superfood Collagen.

Several government authorities provide guidelines for maternal diet. For instance, in May 2022, the U.S. Department of Health & Human Services published an article about nutrients lactating mothers should consume. According to this article, the Dietary Guidelines for Americans suggest that lactating women must consume 550 mg of choline and 290 mcg of iodine daily in the first year postpartum. Such guideline documents published by major regulatory authorities are expected to boost the market growth.

Postpartum Health Supplements Market Report Highlights

• Based on product, the combined nutritional supplements led the market in 2023 with the largest revenue share of 68.10%, owing to the availability of multiple supplements in one product
• The single nutritional supplements segment is expected to grow at a significant CAGR over the forecast period
• Based on formulation, the capsules/tablets segment held the largest revenue share in 2023, owing to its extended shelf-life and easy packaging
• The softgels segment is anticipated to witness significant CAGR over the forecast period. The growth is attributed to its numerous benefits, such as increased bioavailability, easy swallowing & digestion, and convenience
• Based on the sales channel, the pharmacies/drug stores segment led the market with the largest revenue share in 2023, owing to the availability of several types of products from multiple players
• The online sales channel segment is expected to grow at the fastest CAGR during the forecast period, as online distribution channels cater to a more diverse & broader customer base
• Asia Pacific dominated the market, owing to the huge population and birthrate in countries such as China and India
• In August 2023, Biogen, Inc. and Sage Therapeutics, Inc. announced the FDA approval for ZURZUVAE (zuranolone), an adult postpartum depression treatment. ZURZUVAE was expected to launch and be commercially available in the fourth quarter of 2023

Please note The report will be delivered in 2-3 business days upon order notification.